The FDA has approved a new breast cancer drug that avoids healthy cells while it targets tumors, reported the Associated Press. The drug, Kadcyla, is a combination of a chemotherapy drug, another drug called Herceptin, and a chemical that keeps them combined until the drug cocktail meets the tumor. Scientists…
By Amanda Marcotte
Read More
By Amanda Marcotte
Read More
By Pando Daily
Read More
Raw Story is a progressive news site that focuses on stories often ignored in the mainstream media. While giving coverage to the big stories of the day, we also bring our readers' attention to policy, politics, legal and human rights stories that get ignored in an infotainment culture driven solely by pageviews.
Founded in 2004, Raw Story reaches 5 million unique readers per month and serves more than 19 million pageviews.
Copyright © 2004-2013 Raw Story Media, Inc. All rights reserved.